H.C. Wainwright Upgrades Innate Pharma S.A. (IPHA) to Buy

October 29, 2025 6:24 AM EDT Send to a Friend
H.C. Wainwright analyst Swayampakula Ramakanth upgraded Innate Pharma S.A. (NASDAQ: IPHA) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login